Sernova Biotherapeutics (TSX:SVA) Operating Cash Flow per Share : C$-0.06 (TTM As of Jan. 2025)

View and export this data going back to 1998. Start your Free Trial

What is Sernova Biotherapeutics Operating Cash Flow per Share?

Sernova Biotherapeutics's operating cash flow per share for the three months ended in Jan. 2025 was C$-0.02. Sernova Biotherapeutics's operating cash flow per share for the trailing twelve months (TTM) ended in Jan. 2025 was C$-0.06.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -30.30% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -33.90% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was -19.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Sernova Biotherapeutics's Operating Cash Flow per Share or its related term are showing as below:

TSX:SVA' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -377.7 Med: -9.1 Max: 56.5
Current: -30.3

During the past 13 years, Sernova Biotherapeutics's highest 3-Year average Operating Cash Flow per Share Growth Rate was 56.50% per year. The lowest was -377.70% per year. And the median was -9.10% per year.

TSX:SVA's 3-Year OCF Growth Rate is ranked worse than
87.14% of 1221 companies
in the Biotechnology industry
Industry Median: 9.3 vs TSX:SVA: -30.30

Sernova Biotherapeutics Operating Cash Flow per Share Historical Data

The historical data trend for Sernova Biotherapeutics's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sernova Biotherapeutics Operating Cash Flow per Share Chart

Sernova Biotherapeutics Annual Data

Trend

Oct15

Oct16

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

Oct24

Operating Cash Flow per Share

Get a 7-Day Free Trial

-0.02

-0.03

-0.05

-0.10

-0.06

Sernova Biotherapeutics Quarterly Data
	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24	Jan25
Operating Cash Flow per Share	Get a 7-Day Free Trial															-0.01	-0.02	-0.01	-0.01	-0.02

Competitive Comparison of Sernova Biotherapeutics's Operating Cash Flow per Share

For the Biotechnology subindustry, Sernova Biotherapeutics's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sernova Biotherapeutics's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sernova Biotherapeutics's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Sernova Biotherapeutics's Price-to-Operating-Cash-Flow falls into.

Save Embed

;

Save Embed

;

Sernova Biotherapeutics Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Sernova Biotherapeutics's Operating Cash Flow per Share for the fiscal year that ended in Oct. 2024 is calculated as

Operating Cash Flow per Share (A: Oct. 2024 )	=	Cash Flow from Operations (A: Oct. 2024 )	/	Shares Outstanding (Diluted Average) (A: Oct. 2024 )
	=	-18.896	/	306.954
	=	-0.06

Sernova Biotherapeutics's Operating Cash Flow per Share for the quarter that ended in Oct. 2024 is calculated as

Operating Cash Flow per Share (Q: Jan. 2025 )	=	Cash Flow from Operations (Q: Jan. 2025 )	/	Shares Outstanding (Diluted Average) (Q: Jan. 2025 )
	=	-4.827	/	327.475
	=	-0.01

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Jan. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.06

Sernova Biotherapeutics Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Sernova Biotherapeutics's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Sernova Biotherapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sernova Biotherapeutics Inc (TSX:SVA) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

SEOVF:USA PSH0:Germany

Address

700 Collip Circle, Suite 114, London, ON, CAN, N6G 4X8

Website

https://www.sernova.com

Sernova Biotherapeutics Inc is a clinical-stage company developing regenerative medicines. The company develops Cell Pouch with human donor cells or stem cells to create a biohybrid organ. The Cell Pouch is a implantable medical device designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells, which then release proteins, hormones, or other factors into the bloodstream for the long-term treatment of multiple chronic diseases such as type 1 diabetes, hypothyroid disease, and rare diseases such as hemophilia A.

Executives